白念珠菌病的治疗及研究进展  

Advances in treatment and research of candidiasis albicans

作　　者：刘钊 张伶[2] 韩昭[2] 张建忠[2] 牛亮 李小静[2] LIU Zao;ZHANG Ling;HAN Zhao(School of Clinical Medicine,Hebei University of Engineering,Handan 056004,China)

机构地区：[1]河北工程大学临床医学院,邯郸056004 [2]河北工程大学附属医院

出　　处：《实用皮肤病学杂志》2021年第6期347-349,353,共4页Journal of Practical Dermatology

摘　　要：白念珠菌是一种条件性致病菌.随着白念珠菌病患者的增多及耐药性的增加,寻找新的治疗药物成为研究热点.该文从白念珠菌病的传统治疗及目前治疗新进展作一综述,以期为临床用药及相关药物的研发提供参考.Candida albicans is a conditional pathogenic fungus.With the increase of candidiasis albicans patients and the increase of drug resistance of the Candida albicans,the search for new therapeutic drugs has become a hotspot.In this paper,the traditional treatment and recent advances in treatment of candidiasis albicans are reviewed,so as to provide references for clinical medication and related drug development.

关 键 词：白念珠菌病 传统药物 棘白菌素类药物 新型长效 抗菌肽 硫氧还蛋白还原酶抑制剂 丁香酚衍生物 

分 类 号：R756.5[医药卫生—皮肤病学与性病学]